Residual Dyspnea May Predict Small Airways Dysfunction and Poor Responsiveness to Single-Inhaler Triple Therapy in Asthmatic Patients
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Asthma and Allergy"
DOI: 10.2147/jaa.s381953
Abstract: Purpose Recently, single-inhaler triple therapy (SITT) has demonstrated efficacy in patients with uncontrolled asthma who were symptomatic despite treatment with inhaled corticosteroids/long-acting β2 agonists. However, the characteristics of patients who benefit from SITT remain unclear… read more here.
Keywords: inhaler triple; dyspnea; single inhaler; triple therapy ... See more keywords
When single-inhaler triple therapy is a preferred option in asthma management?
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Thoracic Medicine"
DOI: 10.4103/atm.atm_341_22
Abstract: Asthma control is the main goal of management. Unfortunately, most asthma patients with moderate–severe asthma remain uncontrolled despite receiving standard treatment of inhaled corticosteroids (ICS) with long-acting β2 agonists (LABA). The addition of long-acting antimuscarinic… read more here.
Keywords: inhaler triple; single inhaler; option; triple therapy ... See more keywords